Shandong Sito Bio-technology Co., Ltd. (300583.SZ)
- Previous Close
19.26 - Open
19.14 - Bid 20.07 x --
- Ask 20.09 x --
- Day's Range
19.30 - 20.30 - 52 Week Range
10.66 - 31.63 - Volume
4,034,118 - Avg. Volume
4,412,172 - Market Cap (intraday)
3.813B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.64 - Earnings Date --
- Forward Dividend & Yield 0.45 (2.34%)
- Ex-Dividend Date Jul 30, 2024
- 1y Target Est
--
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. The company was founded in 2002 and is based in Heze City, China.
www.sitobiotech.comRecent News: 300583.SZ
View MorePerformance Overview: 300583.SZ
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300583.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300583.SZ
View MoreValuation Measures
Market Cap
3.65B
Enterprise Value
4.20B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.83
Price/Book (mrq)
2.02
Enterprise Value/Revenue
4.26
Enterprise Value/EBITDA
115.33
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.15%
Return on Assets (ttm)
-0.15%
Return on Equity (ttm)
-5.13%
Revenue (ttm)
970.6M
Net Income Avi to Common (ttm)
-88.77M
Diluted EPS (ttm)
-0.64
Balance Sheet and Cash Flow
Total Cash (mrq)
255.96M
Total Debt/Equity (mrq)
40.41%
Levered Free Cash Flow (ttm)
273.51M